Azad Babak
Known title: See RemarksCIK: 0001822193
Associated companies
Transaction History
| GDRX | ▲ Buy | Option Exercise | 20,401 | — | 6/8/2023 | View on chart |
| GDRX | ▼ Sell | Tax Withholding | 7,055 | $38K | 6/8/2023 | View on chart |
| GDRX | ▲ Buy | Option Exercise | 20,402 | — | 3/8/2023 | View on chart |
| GDRX | ▼ Sell | Tax Withholding | 8,089 | $44K | 3/8/2023 | View on chart |
| GDRX | ▲ Buy | Option Exercise | 20,401 | — | 12/8/2022 | View on chart |
| GDRX | ▼ Sell | Tax Withholding | 7,055 | $35K | 12/8/2022 | View on chart |
| GDRX | ▲ Buy | Option Exercise | 12,500 | $74K | 12/9/2021 | View on chart |
| GDRX | ▼ Sell | Open Market | 8,430 | $356K | 12/9/2021 | View on chart |
| GDRX | ▼ Sell | Open Market | 300 | $13K | 12/9/2021 | View on chart |
| GDRX | ▼ Sell | Open Market | 3,770 | $154K | 12/9/2021 | View on chart |
| GDRX | ▲ Buy | Option Exercise | 5,000 | $30K | 11/16/2021 | View on chart |
| GDRX | ▼ Sell | Open Market | 11,700 | $493K | 11/9/2021 | View on chart |
| GDRX | ▲ Buy | Option Exercise | 12,500 | $74K | 11/9/2021 | View on chart |
| GDRX | ▼ Sell | Open Market | 800 | $35K | 11/9/2021 | View on chart |
| GDRX | ▲ Buy | Option Exercise | 7,500 | $45K | 10/11/2021 | View on chart |
| GDRX | ▼ Sell | Open Market | 7,500 | $307K | 10/11/2021 | View on chart |
| GDRX | ▲ Buy | Option Exercise | 12,500 | $74K | 9/9/2021 | View on chart |
| GDRX | ▼ Sell | Open Market | 1,801 | $73K | 9/9/2021 | View on chart |
| GDRX | ▼ Sell | Open Market | 3,400 | $141K | 9/9/2021 | View on chart |
| GDRX | ▼ Sell | Open Market | 7,299 | $310K | 9/9/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 7, 2026
GoodRx Expands Savings Offering With Companion Family Plan for Pets and People
GoodRx has launched a Companion Family Plan that extends its healthcare savings to pets as well as household members. The company is positioning the new offering as a way to bring prescription and care discounts to the entire family, including animals, broadening the appeal of its platform. Separately, a recent market analysis listed GoodRx among stocks viewed as having mixed momentum. The company is already trading near a well-tested support level, providing some technical context around the announcement.
GoodRx Expands Savings Offering With Companion Family Plan for Pets and People. GoodRx has launched a Companion Family Plan that extends its healthcare savings to pets as well as household members. The company is positioning the new offering as a way to bring prescription and care discounts to the entire family, including animals, broadening the appeal of its platform. Separately, a recent market analysis listed GoodRx among stocks viewed as having mixed momentum. The company is already trading near a well-tested support level, providing some technical context around the announcement.